The overall mission of a GVN Regional Headquarters office is to collaborate with the GVN global headquarters located in Baltimore, Maryland, USA. A GVN Regional HQ provides organizational support and leadership to strengthen basic and translational research in virology, as well as preparedness and response to viral pandemic threats.


  • Acting as an “ambassador” of GVN in their respective region to promote and support GVN’s mission and goals
  • Offering administrative and financial support for the daily operation of the regional office
  • Supporting and promoting research in virology and advocating for public health in their regions
  • Supporting training and mentoring the next generation of regional and global leaders in virology and infectious diseases
  • Establishing capacity building for its region through educational and training programs


  • Enhancing its awareness, authority, leadership and visibility in virology at regional, national and international levels
  • Gaining access to GVN resources and network by collaborating with academic and industrial partners
  • Attending the GVN meetings (i.e., annual and regional conferences and meetings for GVN task forces)
  • Interacting and collaborating with internationally renowned virologists
  • Getting access to opportunities for interdisciplinary research projects through grant applications submitted to federal agencies and various foundations
  • Receiving assistance and advice for interventional strategies to mitigate the outbreaks of infectious diseases in their respective regions

For more information, please contact Linman Li, Vice President of the GVN, at [email protected].


GVN Healthcare & Pharma Centers of Excellence

 The business community is an integral partner in stemming the spread of viral diseases worldwide. Viral outbreaks, such as SARS-CoV-2 / COVID19, know no boundaries and spread rapidly beyond national borders, accompanied by panic, uncertainty, and losses to workforces, productivity and revenue streams. Multinational corporations and businesses with international interests are vital partners in preparations against current and future potential pandemics and in stopping the spread of viruses.

The main goal of the GVN Healthcare & Pharma Centers of Excellence Coalition is to link the business community with leading medical virologists, support cutting edge viral research, drug and vaccine development and training activities, increase awareness of medical virology issues and serve as a platform for partnerships to strengthen international viral preparedness and response.

As part of the GHPC, participating corporations will be incorporated as a “GVN Healthcare & Pharma Center of Excellence”. This will allow access and cooperation with GVN Academic Centers of Excellence to the mutual benefit of the GVN and GVN Healthcare & Pharma Centers of Excellence Coalition.

This mutually beneficial partnership includes:

  • Research Collaboration
  • Training Future Virologists
  • New Strategic Partners
  • Visibility and Impact
  • Attendance at the annual and reginal GVN meetings.
  • Outbreak Notification, Evaluation & Response Briefings.

If you are interested in joining the coalition, please contact Linman Li, Vice President of the GVN, at [email protected].



For nearly three decades Abbott has monitored HIV and hepatitis viruses and identified mutations which help ensure the company’s diagnostic tests remain up to date through its Global Surveillance Program.

The surveillance program continues to be a pathway fueled by collaboration, enabling researchers to proactively evaluate and solve infectious disease challenges. In partnership with institutions around the world, the program has collected more than 78,000 samples containing HIV and hepatitis viruses, identified and characterized thousands of strains, and published 143 research papers to date to help the scientific community learn more about viruses and mutations. Most recently the company unveiled the Abbott Pandemic Defense Coalition – a first-of-its-kind global scientific and public health partnership dedicated to the early detection of — and rapid response to — future pandemic threats.

Recent publications:

1) Michael G. Berg, Ana Olivo, Barbara J. Harris, Mary A. Rodgers, Linda James, Samuel Mampunza, Jonathon Niles, Franklin Baer, Julie Yamaguchi, Lazare Kaptue, Oliver Laeyendecker, Tom Quinn, Carole McArthur, Gavin A. Cloherty. A high prevalence of potential elite HIV viral controllers identified over 30 years in Democratic Republic of Congo. eBiomedicine.

2) Berg MG, Olivo A, Forberg K, Harris BJ, Yamaguchi J, Shirazi R, Gozlan Y, Sauleda S, Kaptue L, Rodgers MA, Mor O, Cloherty GA. Advanced molecular surveillance approaches for characterization of blood borne hepatitis viruses. PLoS One (2020) Jul 17;15(7):e0236046.

3) Yamaguchi J, McArthur C, Vallari A, Sthreshley L, Cloherty GA, Berg MG, Rodgers MA. Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L. JAIDS. (2020) Mar 1;83(3):319-322. PMID 31693506.

Learn more about Abbott’s surveillance work including its Pandemic Defense Coalition and recent HIV discovery.

Follow Abbott on Twitter: @AbbottNews 



Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.

Sanofi, Empowering Life


About GVN Centers of Excellence

We represent Centers of Excellence for research in medical virology from across the globe. Our work is dedicated to understanding, preventing and eradicating viral disease threats to mankind. Today, we affirm the need for new programs to coordinate, support and promote research that bridges the gap between virus surveillance and public health implementation.

Criteria for a GVN Center of Excellence 

1) The Director is a noted medical virologist.

2) The center is currently productive, and has deep expertise in 2-3 viral areas.

3) The center is committed to capacity building in weaker institutes especially in resource-poor nations.

4) There is commitment to work to support GVN’s central operation through inclusion on grant and contract applications, fundraising events, direct donations or other means.

About GVN Affiliates

Affiliates are virus research institutions that are members of the GVN through an existing GVN Center of Excellence.  Affiliates, which are “twinned” with GVN Centers of Excellence, work closely with these appointed Centers to grow their expertise.

If you are interested in joining the GVN Centers of Excellence/Affiliates, please contact Marcus Gallo, Research Analyst, Virus Watch Group & Centers Coordinator, at [email protected].